Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lobna Ibrahim

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
CNS Neuroscience & Therapeutics|October 22, 2010
Histone deacetylases and mood disorders: epigenetic programming in gene-environment interactionsRodrigo Machado-Vieira, Lobna Ibrahim, Carlos A Zarate
Medical Hypotheses|June 14, 2011
SSRIs and placental dysfunctionAlok Banga, Venkatesh Handratta, Lobna Ibrahim, et al.
Archives of Physiology and Biochemistry|March 20, 2020
Sensitivity of serum S100B protein as a disease activity marker in Egyptian patients with vitiligo (case-control study)Fatma H Shabaka, Laila A Rashed, Marwa Said, et al.
Pharmacology, Biochemistry, and Behavior|October 6, 2011
Novel glutamatergic agents for major depressive disorder and bipolar disorderRodrigo Machado-Vieira, Lobna Ibrahim, Ioline D Henter, et al.
Hematology (Amsterdam, Netherlands)|November 23, 2017
Prognostic impact of CD200 and CD56 expression in adult acute lymphoblastic leukemia patientsSalah Aref, Emad Azmy, Kadry El-Bakry, et al.
Pediatric Hematology and Oncology|November 18, 2017
Prognostic impact of CD200 and CD56 expression in pediatric B-cell acute lymphoblastic leukemia patientsSalah Aref, Emad Azmy, Kadry El-Bakry, et al.
Harvard Review of Psychiatry|September 10, 2010
Glutamatergic modulators: the future of treating mood disorders?Carlos Zarate, Rodrigo Machado-Vieira, Ioline Henter, et al.
Brain Research Bulletin|June 28, 2011
Rapid antidepressant changes with sleep deprivation in major depressive disorder are associated with changes in vascular endothelial growth factor (VEGF): a pilot studyLobna Ibrahim, Wallace Duncan, David A Luckenbaugh, et al.
Functional & Integrative Genomics|June 10, 2025
Unveiling the Therapeutic Potential of Targeting RRM2 in Hepatocellular Carcinoma: An Integrated In Silico and In Vitro StudyLobna Ibrahim, Rania Hassan Mohamed, Mahmoud M Tolba, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 7, 2011
Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depressionLobna Ibrahim, Nancy Diazgranados, David A Luckenbaugh, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
CNS Neuroscience & Therapeutics|October 22, 2010
Histone deacetylases and mood disorders: epigenetic programming in gene-environment interactionsRodrigo Machado-Vieira, Lobna Ibrahim, Carlos A Zarate
Medical Hypotheses|June 14, 2011
SSRIs and placental dysfunctionAlok Banga, Venkatesh Handratta, Lobna Ibrahim, et al.
Archives of Physiology and Biochemistry|March 20, 2020
Sensitivity of serum S100B protein as a disease activity marker in Egyptian patients with vitiligo (case-control study)Fatma H Shabaka, Laila A Rashed, Marwa Said, et al.
Pharmacology, Biochemistry, and Behavior|October 6, 2011
Novel glutamatergic agents for major depressive disorder and bipolar disorderRodrigo Machado-Vieira, Lobna Ibrahim, Ioline D Henter, et al.
Hematology (Amsterdam, Netherlands)|November 23, 2017
Prognostic impact of CD200 and CD56 expression in adult acute lymphoblastic leukemia patientsSalah Aref, Emad Azmy, Kadry El-Bakry, et al.
Pediatric Hematology and Oncology|November 18, 2017
Prognostic impact of CD200 and CD56 expression in pediatric B-cell acute lymphoblastic leukemia patientsSalah Aref, Emad Azmy, Kadry El-Bakry, et al.
Harvard Review of Psychiatry|September 10, 2010
Glutamatergic modulators: the future of treating mood disorders?Carlos Zarate, Rodrigo Machado-Vieira, Ioline Henter, et al.
Brain Research Bulletin|June 28, 2011
Rapid antidepressant changes with sleep deprivation in major depressive disorder are associated with changes in vascular endothelial growth factor (VEGF): a pilot studyLobna Ibrahim, Wallace Duncan, David A Luckenbaugh, et al.
Functional & Integrative Genomics|June 10, 2025
Unveiling the Therapeutic Potential of Targeting RRM2 in Hepatocellular Carcinoma: An Integrated In Silico and In Vitro StudyLobna Ibrahim, Rania Hassan Mohamed, Mahmoud M Tolba, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 7, 2011
Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depressionLobna Ibrahim, Nancy Diazgranados, David A Luckenbaugh, et al.
Pageof 2